Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Dysregulation of the glutamatergic system can lead to neurotoxicity, negatively impacting neurotransmission, neuroenergetics, and cell viability. Additionally, abnormalities in this system may be partially related to synaptic abnormalities observed in mood disorders.
Preliminary clinical trials have shown significant antidepressant effects for some therapies targeting the glutamatergic system, including: